Share on Facebook
Share on Twitter
Share on LinkedIn
Email- You are here:
- Home
- >
- Guidelines in Practice
- >
- Volume 13 - Edition 4
Volume 13 Issue 4 - April 2010
| Colour Key: | |
| NICE or Department of Health guideline | |
| SIGN guideline | |
| Independent professional body guideline | |
| Working party guideline | |
| Other articles |
| Editorial | |
| Management of obesity is a major health priority | |
| News | |
| SIGN updates guideline on management of diabetes | |
| Editorial | |
| Variability in blood pressure is a predictor of stroke | |
| Dr Alan Begg reviews recent analyses on the clinical impact of visit-to-visit variability of BP and the effect of different drug classes | |
| Personal View | |
| SIGN provides best practice advice on care of obesity | |
| Dr Matt Capehorn reiterates the importance of primary care in the prevention and management of the obesity epidemic | |
| New Guideline | |
| Suspected Parkinson’s disease should be referred untreated | |
| Dr Katherine Grosset, Dr Graeme Macphee, and Dr Donald Grosset review the SIGN guideline on the diagnosis and pharmacological management of Parkinson’s disease | |
| Guideline Revisited | |
| Atopic eczema can have a significant impact on patients and carers | |
| Management of atopic eczema in children should include assessment of psychosocial factors and avoidance of irritants and triggers, says Dr Nigel Stollery | |
| Guideline Revisited | |
| Breakthrough pain is often poorly controlled in patients with cancer | |
| Dr Andrew Davies discusses current pharmacological options and the benefits that novel formulations can bring in the management of breakthrough cancer pain | |
| Out of Hours | |
| Being a doctor means having difficult conversations | |
| Dr Phil Hammond, broadcaster and sessional GP in Bristol | |
Guidelines in Practice, April
2010, Volume 13 (4)
© 2010 MGP
Ltd
further information | subscribe